(Q92182863)

English

Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: A study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network

scientific article published on 23 July 2019

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: A study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network (CIRN) (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Streptococcus pneumoniae

1 reference

based on heuristic

inferred from title

12

object named as

Guy Boivin

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Shelly A McNeil

23

object named as

Shelly A McNeil

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Melissa K Andrew

11

object named as

Melissa K Andrew

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

18

object named as

Allison McGeer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Rachel Karen Green

14

object named as

Karen Green

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

6

object named as

Todd F Hatchette

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

16

object named as

Mark Loeb

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

22

object named as

Duncan Webster

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

5

object named as

Ardith Ambrose

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Jennie Johnstone

15

object named as

Jennie Johnstone

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

2

object named as

May ElSherif

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Jason J LeBlanc

1

object named as

Jason J LeBlanc

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Donna MacKinnon-Cameron

4

object named as

Donna MacKinnon-Cameron

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Hayley D Gillis

8

object named as

Hayley D Gillis

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

10

object named as

Walter Demczuk

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

author name string

Lingyun Ye

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Amanda L S Lang

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Irene Martin

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

William Bowie

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Anne E McCarthy

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Makeda Semret

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Sylvie Trottier

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Louis Valiquette

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

publication date

23 July 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

37

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

36

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

5466-5473

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Burden of vaccine-preventable pneumococcal disease in hospitalized adults: A Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) network study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

A systematic review of the burden of vaccine preventable pneumococcal disease in UK adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Pneumococcal Capsules and Their Types: Past, Present, and Future

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000–2007

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Changing Epidemiology of Invasive Pneumococcal Disease in Canada, 1998–2007: Update from the Calgary‐Area Streptococcus pneumoniae Research (CASPER) Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995-2011.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

The burden of pneumococcal disease in the Canadian population before routine use of the seven-valent pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Incidence of invasive pneumococcal disease before and during an era of use of three different pneumococcal conjugate vaccines in Quebec

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010–2012

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Effect of the different 13-valent pneumococcal conjugate vaccination uptakes on the invasive pneumococcal disease in children: Analysis of a hospital-based and population-based surveillance study in Madrid, Spain, 2007-2015.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Recommendations for pneumococcal immunization outside routine childhood immunization programs in Western Europe

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Detection and prediction of Streptococcus pneumoniae serotypes directly from nasopharyngeal swabs using PCR.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Diagnostic accuracy of a serotype-specific antigen test in community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Validation of an immunodiagnostic assay for detection of 13 Streptococcus pneumoniae serotype-specific polysaccharides in human urine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Comparative immunogenicity of 7 and 13-valent pneumococcal conjugate vaccines and the development of functional antibodies to cross-reactive serotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Pneumococcal serotype distribution in adults with invasive disease and in carrier children in Italy: Should we expect herd protection of adults through infants' vaccination?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Serotype 3 Remains the Leading Cause of Invasive Pneumococcal Disease in Adults in Portugal (2012-2014) Despite Continued Reductions in Other 13-Valent Conjugate Vaccine Serotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Demonstration of the herd effect in adults after the implementation of pneumococcal vaccination with PCV13 in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

PCV13 serotype decrease in Italian adolescents and adults in the post-PCV13 era: Herd protection from children or secular trend?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

The herd effects of infant PCV7/PCV13 sequential implementation on adult invasive pneumococcal disease, six years post implementation; a nationwide study in Israel

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Pneumococcal Community-Acquired Pneumonia Detected by Serotype-Specific Urinary Antigen Detection Assays

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Characteristics and Serotype Distribution of Childhood Cases of Invasive Pneumococcal Disease Following Pneumococcal Conjugate Vaccination in England and Wales, 2006-2014.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Pneumococcal conjugate vaccine herd effects on non-invasive pneumococcal pneumonia in elderly

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Commentary on paradoxical observations pertaining to the impact of the 13-valent pneumococcal conjugate vaccine on serotype 3 Streptococcus pneumoniae infections in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

The effectiveness of pneumococcal polysaccharide vaccine 23 (PPV23) in the general population of 50 years of age and older: A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Pneumococcal Disease and the Effectiveness of the PPV23 Vaccine in Adults: A Two-Stage Bayesian Meta-Analysis of Observational and RCT Reports

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Effectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic review and meta-analyses of observational studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Identifiers

10.1016/J.VACCINE.2019.05.003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q92182863&oldid=1775327894"